Quantum-Si incorporated
$0.96+20.5%YTD-16.7%1Y-31.1%
Price updated 6h ago
On X
The complete picture of $QSI on X — how loud the conversation is right now, how it has trended over the last two weeks, and which way the crowd is leaning.
0X posts · last 7 days
No mention history yetWhat it does
Plain-English summary of the business — what they sell and how they make money.
Industry overviewAI analysisGenerated by AI from underlying data
Where Medical - Devices sits in its cycle right now — and what that implies for $QSI.
Medical - Devices
Aging population demographics and AI-assisted device adoption (smart implants, continuous glucose monitors, digital health integration) are the long-cycle structural drivers. Reimbursement timing for new modalities (CMS coverage decisions) and procedure volume recovery from COVID-era deferred care shape the 2026 revenue trajectory.
Industry benchmark
18-name peer basket
+17.1%YTD
+28.2%1Y
Fundamentals & catalyst
Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.
Key ratios
P/E
-2.1How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.ROIC
-51.8%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.Op margin
-59.3%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.FCF yield
-49.4%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).P/S
118.1Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.ROE
-47.1%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.Gross margin
35.0%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.D/E
0.0Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.Past earnings
QuarterReportedActualEstimateSurprise
Q2 2026Aug 13, 2026$-0.11$-0.11+2.9%
Q1 2026May 7, 2026$-0.10$-0.12+16.7%
Q4 2025Mar 3, 2026$-0.08$-0.14+42.9%
Q3 2025Nov 5, 2025$-0.17$-0.12-41.7%
Next earningsWed, Nov 4·consensus EPS $-0.13
Quarterly trend
QuarterRevenueYoYGrossOpEPSFCF
Q2 FY26$344K-41.8%50.0%-7450%$-0.11$-18.5M
Q1 FY26$258K-69.4%28.7%-9323%$-0.10$-25.9M
Q4 FY25$451K-62.2%27.1%-4677%$-0.08$-16.3M
Q3 FY25$552K-29.9%35.1%-4420%$-0.17$-32.9M
Forward consensus
FYRevenueRangeEPSRangeAnalysts
FY26$1.1M$848K – $1.3M-$0.43-$0.53 – -$0.292
FY27$5.8M$4.3M – $6.8M-$0.36-$0.44 – -$0.242
FY28$21.6M$15.1M – $26.2M-$0.26-$0.30 – -$0.243
FY29$57.3M$42.9M – $67.5M-$0.18-$0.22 – -$0.121
FY30$105.9M$79.3M – $124.6M-$0.09-$0.11 – -$0.062
Setup & momentum
Volume, range, and moving-average position — the technical setup driving short-term moves.
Right now
Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.10.9×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.11%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+23.8%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+1.0%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.
Float & profile
FloatMid float · 170.1M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today13.5% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β3.255-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.
Insider activity
Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.
SEC filings
Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.
Recent material filings
8-KPress release / Reg FDSep 298-K — Item 7.01: Press release / Reg FD
SC 13D/AActivist amendmentAug 28SC 13D/A
8-KListing / delisting noticeJul 248-K — Item 3.01: Listing / delisting notice
8-KMaterial agreementJun 248-K — Item 1.01: Material agreement · Item 2.03: Material debt obligation
8-KShareholder voteMay 158-K — Item 5.07: Shareholder vote
+ 7 other (2 10-Qs · 2 earnings 8-Ks · 1 13G · 1 25-NSE) in window
Recent news
Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.
Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® ProQuantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European CitiesQuantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment ConferenceQuantum-Si incorporated (QSI) Q2 2026 Earnings Call Transcript
In themes
Explore the broader themes this ticker is being talked about under.
More in Medical - Devices
Peers in the same group — one click to compare setups, fundamentals, and chatter.
Voices on X · last 7 days
No standout posts about $QSI on X in the last 7 days.